Microbot Medical Inc. (MBOT)
Health Care · Surgical robotics / endoluminal medical devices · Nasdaq
Microbot Medical is an early-stage medical device company developing next-generation robotic endoluminal surgical systems for minimally invasive interventional procedures.
What Microbot Medical Inc. does
Microbot Medical is a medical device company specializing in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company is commercializing the LIBERTY Endovascular Robotic Surgical System. As of December 31, 2025, the company had not recognized any revenues from product sales and is in an early commercial stage with significant ongoing R&D and regulatory compliance efforts.
Themes: ["Surgical robotics"]
Fundamentals
- Price$1.89 as of 2026-07-10 close
- Market cap$127M as of 2026-07-13
- 1-year return-28.4% as of 2026-07-10 close
- Net margin-3496.2% as of 2026-07-13
- Gross margin+1.9% as of 2026-07-13
- ROE-21.8% as of 2026-07-13
- Debt / equity0.00 as of 2026-07-13
- Revenue growth (YoY)-50.0% as of 2026-07-13
- Revenue CAGR (3y)-56.0% SEC XBRL
- Beta1.03 as of 2026-07-13
Key risks (from latest filing)
["No revenue recognition through December 31, 2025, and no assurance of generating significant revenues in the future; the company expects to incur significant operating losses for the foreseeable future."]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.